- Report
- November 2023
- 175 Pages
Global
From €4760EUR$5,000USD£4,083GBP
- Report
- October 2023
- 236 Pages
Global
From €5235EUR$5,499USD£4,491GBP
- Report
- October 2023
- 142 Pages
Global
From €2379EUR$2,499USD£2,041GBP
- Clinical Trials
- May 2023
- 250 Pages
Global
From €2285EUR$2,400USD£1,960GBP
€2856EUR$3,000USD£2,450GBP
- Report
- August 2023
- 739 Pages
Global
From €2380EUR$2,500USD£2,042GBP
- Newsletter
- December 2023
Global
From €1010EUR$1,136USD£897GBP
- Report
- May 2023
- 395 Pages
Global
From €3975EUR$4,175USD£3,409GBP
- Report
- February 2023
- 340 Pages
Global
From €4766EUR$5,182USD£3,950GBP
- Report
- February 2023
- 250 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- October 2023
- 150 Pages
Global
From €4617EUR$4,850USD£3,961GBP
- Report
- March 2023
- 145 Pages
Global
From €2379EUR$2,499USD£2,041GBP
- Report
- September 2023
- 100 Pages
Global
From €5665EUR$5,950USD£4,859GBP
- Report
- December 2023
- 193 Pages
Global
From €5189EUR$5,450USD£4,450GBP
- Report
- December 2023
- 360 Pages
Global
From €5189EUR$5,450USD£4,450GBP
- Report
- June 2023
- 275 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- September 2023
- 175 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- September 2023
- 175 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- September 2023
- 175 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- August 2023
- 175 Pages
Global
From €3808EUR$4,000USD£3,266GBP
€4760EUR$5,000USD£4,083GBP
- Report
- May 2023
- 404 Pages
Global
From €4760EUR$5,000USD£4,083GBP
The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more
